SC 13G/A: CervoMed Inc.

AI Summary

SC 13G/A filing by CervoMed Inc..

Risk Assessment

Risk Level: low

FAQ

Key Financial Figures

• $0.001 — me of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securiti
• $19 — LLC exercisable at a price per share of $19.81, on or before April 2, 2028 (the War

Filing Documents

• d789294dsc13ga.htm (SC 13G/A) — 76KB
• d789294dex991.htm (EX-99.1) — 7KB
• 0001193125-24-035273.txt ( ) — 85KB

From the Filing

SC 13G/A 1 d789294dsc13ga.htm SC 13G/A SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* CervoMed Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 15713L109 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the Act) or otherwise subject to the liabilities of the section of the Act but shall be subject to all other provisions of that Act (however, see the Notes). CUSIP No. 15713L109 1. NAMES OF REPORTING PERSONS AI EIPP Holdings LLC 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a)(b) 3. SEC USE ONLY: 4. CITIZENSHIP OR PLACE OF ORGANIZATION: Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER: 0 6. SHARED VOTING POWER: 428,203 (1) 7. SOLE DISPOSITIVE POWER: 0 8. SHARED DISPOSITIVE POWER: 428,203 (1) 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON: 428,203 (1) 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS): 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9): 7.49% (2) 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS): OO (Limited Liability Company) (1) Represents (i) 385,647 shares of the Issuers Common Stock, and (ii) 42,556 shares of Common Stock underlying pre-funded warrants held by AI EIPP Holdings, LLC exercisable at a price per share of $19.81, on or before April 2, 2028 (the Warrants). (2) Based on 5,674,520 shares of the Issuers Common Stock outstanding as of November 9, 2023, as reported in the Issuers Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (the SEC) on November 13, 2023. 2 CUSIP No. 15713L109 1. NAMES OF REPORTING PERSONS Access Industries Management, LLC 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a)(b) 3. SEC USE ONLY: 4. CITIZENSHIP OR PLACE OF ORGANIZATION: Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER: 0 6. SHARED VOTING POWER: 428,203 (1) 7. SOLE DISPOSITIVE POWER: 0 8. SHARED DISPOSITIVE POWER: 428,203 (1) 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON: 428,203 (1) 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS): 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9): 7.49% (2) 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS): OO (Limited Liability Company) (1) Represents (i) 385,647 shares of the Issuers Common Stock, and (ii) 42,556 shares of Common Stock underlying the Warrants. (2) Based on 5,674,520 shares of the Issuers Common Stock outstanding as of November 9, 2023, as reported in the Issuers Quarterly Report on Form 10-Q filed with the SEC on November 13, 2023. 3 CUSIP No. 15713L109 1. NAMES OF REPORTING PERSONS Len Blavatnik 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a)(b) 3. SEC USE ONLY: 4. CITIZENSHIP OR PLACE OF ORGANIZATION: United States of America NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER: 0 6. SHARED VOTING POWER: 428,203 (1) 7. SOLE DISPOSITIVE POWER: 0 8. SHARED DISPOSITIVE POWER: 428,203 (1) 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON: 428,203 (1) 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS): 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9): 7.49% (2) 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS): IN (1) Represents (i) 385,647 shares of the Issuers Common Stock, and (ii) 42,556 shares of Common Stock underlying the Warrants. (2) Based on 5,674,520 shares of the Issuers Common Stock outstanding as of November 9, 2023, as reported in the Issuers Quarterly Report on Form 10-Q filed with the SEC on November 13, 2023. 4 Schedule 13G CUSIP No. 15713L109 Item1. (a) Name of Issuer: CervoMed Inc. (the Issuer). (b) Address of Issuers Principal Executive Offices: 20 Park Plaza, Suite 424 Boston, Massachusetts 02216 Item2. (a) Name of Person Filing: This filing is being made on behalf of (collectively, the Access Filers): AI EIPP

View Full Filing

View this SC 13G/A filing on SEC EDGAR